OCULUS

Frankfurt Am Main, Germany Founded: 1895 • Age: 131 yrs
Eye diagnostic equipment is developed for ophthalmological applications.

About OCULUS

OCULUS is a Healthcare company based in Frankfurt Am Main (Germany) founded in 1895. Eye diagnostic equipment is developed for ophthalmological applications. Its website oculus.de draws about 40 thousand monthly visits. Its focus areas include Life Sciences, Ophthalmology, Medical Devices and Imaging.

Company details

Oculus develops a range of eye diagnostic equipment for the oncological market. The company has eight subsidiaries in Europe, Asia, and America. The company has developed products such as the Pentacam (anterior segment analysis), manual refraction, binocular loupes, Perimetry systems, Refraction equipment, Keratograph and Easyfield Topography systems, etc. The company also provides training and educational resources, which are accessible 247 in its online library or offline during many in house training sessions throughout the year. The company also offers Vitreoretinal Surgery equipment such as BIOM range, ImproVue, and SDI.

Operational Areas
Key Metrics

Funding Insights of OCULUS

  • Total Rounds 1
  • Last Round Grant β€” $371,418
  • First Round $371,418

    (Jan 2018)

  • Investors Count 1

All 1 funding rounds of OCULUS with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jan 2018$371,418Grant––
Valuation history

1 investors in total: 1 institutional.

Investors in OCULUS

OCULUS has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
Premium access

Investor details for OCULUS

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of OCULUS

2 dated milestones of OCULUS across 123 years, from founding to its latest funding, stage changes and deals.

  1. Founded OCULUS is founded.
  2. Funding First funding round of $371K.

Web traffic of OCULUS

The website of OCULUS (oculus.de) receives about 40K visits a month.

  • Monthly visits
    40K

    ▲ 25.2% vs previous month

Similar websites

Websites whose visitors overlap most with OCULUS. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
angelusmedical.com
angelusmedical.com
100%
#1,432,141–
iclinic.at
iclinic.at
100%
#1,456,548–
bon.de
bon.de
94%
#3,032,059–
precision-vision.com
precision-vision.com
94%
#811,704–
amconlabs.com
amconlabs.com
93%
#792,428–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 34 similar websites and full traffic analytics for OCULUS

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 34 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Oculus

Premium access

Complete news archive for OCULUS

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about OCULUS

OCULUS was founded in 1895 and raised its 1st funding round 123 years after it was founded.

OCULUS is headquartered in Frankfurt Am Main, Germany. It is registered at Frankfurt Am Main, Hesse, Germany.

Oculus develops a range of eye diagnostic equipment for the oncological market. The company has eight subsidiaries in Europe, Asia, and America. The company has developed products such as the Pentacam (anterior segment analysis), manual refraction, binocular loupes, Perimetry systems, Refraction equipment, Keratograph and Easyfield Topography systems, etc. The company also provides training and educational resources, which are accessible 247 in its online library or offline during many in house training sessions throughout the year. The company also offers Vitreoretinal Surgery equipment such as BIOM range, ImproVue, and SDI.

OCULUS has 1 investor. Key investors include European Union.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available